BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34565327)

  • 1. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients.
    Wang WM; Wu C; Gao YM; Li F; Yu XL; Jin HZ
    BMC Immunol; 2021 Sep; 22(1):64. PubMed ID: 34565327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the inflammatory parameters as potential biomarkers of systemic inflammation extent and the disease severity in psoriasis patients.
    Zhang Y; Qian H; Kuang YH; Wang Y; Chen WQ; Zhu W
    Arch Dermatol Res; 2024 May; 316(6):229. PubMed ID: 38787405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Mean Platelet Volume in Egyptian Patients with Psoriasis Vulgaris.
    Hammad R; Hamdino M; El-Nasser AM
    Egypt J Immunol; 2020 Jan; 27(1):157-168. PubMed ID: 33180397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics.
    Asahina A; Kubo N; Umezawa Y; Honda H; Yanaba K; Nakagawa H
    J Dermatol; 2017 Oct; 44(10):1112-1121. PubMed ID: 28493493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of novel complete blood count-derived inflammatory markers with psoriasis: a systematic review and meta-analysis.
    Liu YC; Chuang SH; Chen YP; Shih YH
    Arch Dermatol Res; 2024 May; 316(6):228. PubMed ID: 38787437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis.
    Kim DS; Shin D; Lee MS; Kim HJ; Kim DY; Kim SM; Lee MG
    J Dermatol; 2016 Mar; 43(3):305-10. PubMed ID: 26381893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple tool for evaluation of inflammation in psoriasis: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as markers in psoriasis patients and related murine models of psoriasis-like skin disease.
    Kommoss KS; Bieler T; Ringen J; Lehmann A; Mihalceanu S; Hobohm L; Keller K; Brand A; Fischer B; Kramer D; Wild J; Waisman A; Enk A; Schäkel K; Heikenwälder M; Karbach S
    J Mol Med (Berl); 2024 Feb; 102(2):247-255. PubMed ID: 38127137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship of Hematological Parameters and C-reactive Protein (CRP) With Disease Presence, Severity, and Response to Systemic Therapy in Patients With Psoriasis.
    Şener G; İnan Yuksel E; Gökdeniz O; Karaman K; Canat HD
    Cureus; 2023 Aug; 15(8):e43790. PubMed ID: 37731441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there any Correlation between Red Cell Distribution Width, Mean Platelet Volume Neutrophil Count, Lymphocyte Count, and Psoriasis Area Severity Index in Patients Under Treatment for Psoriasis?
    Balevi A; Olmuşçelik O; Ustuner P; Özdemir M
    Acta Dermatovenerol Croat; 2018 Oct; 26(3):199-205. PubMed ID: 30390720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between generalized epileptic seizure and neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and neutrophil mediated inflammation.
    Güneş M; Büyükgöl H
    Int J Neurosci; 2020 Nov; 130(11):1095-1100. PubMed ID: 31983256
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Turkish patients with chronic plaque psoriasis.
    Polat M; Bugdayci G; Kaya H; Oğuzman H
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Dec; 26(4):97-100. PubMed ID: 29264899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study.
    Nguyen HT; Vo LDH; Pham NN
    Dermatol Reports; 2023 Mar; 15(1):9516. PubMed ID: 37063396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Elevated Serum Uric Acid Levels on Systemic Inflammation in Patients With Psoriasis.
    Solak B; Dikicier BS; Erdem T
    Angiology; 2017 Mar; 68(3):266-270. PubMed ID: 27401209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.
    Uslu AU; Küçük A; Şahin A; Ugan Y; Yılmaz R; Güngör T; Bağcacı S; Küçükşen S
    Int J Rheum Dis; 2015 Sep; 18(7):731-5. PubMed ID: 25900081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis.
    Yurtdaş M; Yaylali YT; Kaya Y; Ozdemir M; Ozkan I; Aladağ N
    Echocardiography; 2014 Oct; 31(9):1095-104. PubMed ID: 24447343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in psoriasis: a systematic review and meta-analysis.
    Ye JH; Zhang Y; Naidoo K; Ye S
    Arch Dermatol Res; 2024 Feb; 316(3):85. PubMed ID: 38329632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-Lymphocyte Ratio, Neutrophil-to-Monocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index in Psoriasis Patients: Response to Treatment with Biological Drugs.
    Albayrak H
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis.
    Sen BB; Rifaioglu EN; Ekiz O; Inan MU; Sen T; Sen N
    Cutan Ocul Toxicol; 2014 Sep; 33(3):223-7. PubMed ID: 24147939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of IL17 and IL23 inhibitors on hematological parameters and C-reactive protein in psoriasis patients.
    Esen M
    Cutan Ocul Toxicol; 2024 Mar; 43(1):38-45. PubMed ID: 37897439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus.
    Wu Y; Chen Y; Yang X; Chen L; Yang Y
    Int Immunopharmacol; 2016 Jul; 36():94-99. PubMed ID: 27111516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.